• Tchaikapharma was granted Marketing authorization for a new drug anti-hypertension drug

    November 16, 2023

    The latest medicinal product to receive Marketing Authorisation from the Bulgarian Drug Agency is:


    Ferbessa 4 mg/5 mg tablets


    Ferbessa 8 mg/5 mg tablets


    Ferbessa is a combination of the two active substances: perindopril and amlodipine. Perindopril is an angiotensin-converting enzyme inhibitor (ACE inhibitor). Amlodipine is a calcium antagonist that belongs to a class of drugs called dihydropyridines.


    Together, they help blood vessels to dilate and relax so that blood flows more easily through them and makes it easier for the heart to maintain good blood flow.


    Ferbessa is indicated as replacement therapy for the treatment of essential hypertension and/or stable coronary artery disease in patients previously controlled with perindopril and amlodipine taken alternatively at the same dosage. The fixed combination is not suitable for initial treatment.


    The medicinal product is available on prescription.


    ATC code: C09BB04